CardiaTec Biosciences ^Companies

CardiaTec Biosciences is a digital biotechnology venture that combines the power of AI and expert talent to redesign cardiovascular drug discovery. They are applying artificial intelligence on large-scale multi-omic data to develop the next generation of drug targets for cardiovascular disease. With cardiovascular disease being the leading global cause of death, claiming over 17 million lives each year, CardiaTec aims to address the underfunding and stagnation of therapeutic innovation in this field. Their AI-driven multi-omics analysis platform has the potential to unravel relationships and uncover new drug targets, filling the unmet need for patients in the cardiovascular field.